Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.

BACK TO LIST

Patient
Name:	Prażmo, , Aniela,
DOB:	08-FEB-1941 (Age: 84)
Gender:	female
Address:	pl. Kołłątaja 62/43 97-200 Tomaszów Mazowiecki (Poland)
ID:	9657-869171-7 (ECI)

Report
Date:	10-JUN-2023

Laboratory
dr Ample, Ex Laboratoire Central Européenne Boulevard du Jardin Botanique 32 1000 Brussels (Belgium)

Requested by
Poradnia rehabilitacyjna 97-200 Tomaszów Mazowiecki (Poland)

Specimen
Collected:	10-JUN-2023

Chemistry

Test	10-JUN-2023	Reference Range	Unit
Cholesterol [Mass/volume] in Serum or Plasma	255.2 H	130 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	109.6	0 - 199	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	174.7 H	0 - 130	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	58.6	50 - 100	mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows elevated total cholesterol and LDL cholesterol, both above recommended levels, indicating increased cardiovascular risk. Triglycerides and HDL cholesterol are within normal limits. Lipid-lowering therapy and lifestyle modifications should be considered in consultation with the treating physician. Regular monitoring is advised.